Cite
Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study.
MLA
Bolignano, Davide, et al. “Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study.” Medicina (Kaunas, Lithuania), vol. 60, no. 7, June 2024. EBSCOhost, https://doi.org/10.3390/medicina60071079.
APA
Bolignano, D., Serraino, G. F., Pizzini, P., Jiritano, F., Zicarelli, M., Spoto, B., Mobrici, M., Musolino, M., Napolitano, D., Testa, A., Andreucci, M., Mastroroberto, P., & Coppolino, G. (2024). Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study. Medicina (Kaunas, Lithuania), 60(7). https://doi.org/10.3390/medicina60071079
Chicago
Bolignano, Davide, Giuseppe Filiberto Serraino, Patrizia Pizzini, Federica Jiritano, Mariateresa Zicarelli, Belinda Spoto, Marco Mobrici, et al. 2024. “Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study.” Medicina (Kaunas, Lithuania) 60 (7). doi:10.3390/medicina60071079.